Sucampo Pharma Americas, LLC
18
0
0
15
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
16.7%
3 terminated/withdrawn out of 18 trials
83.3%
-3.2% vs industry average
72%
13 trials in Phase 3/4
107%
16 of 15 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (18)
Lubiprostone in Children With Functional Constipation
Role: lead
Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional Constipation
Role: lead
Comparative Pharmacokinetics and Food-Effect Bioavailability of Lubiprostone Sprinkle in Healthy Volunteers
Role: lead
Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL)
Role: lead
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
Role: lead
Lubiprostone for Children With Constipation
Role: lead
Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo
Role: lead
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Role: lead
Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury
Role: lead
Safety and Efficacy of Lubiprostone in Pediatric Patients With Constipation
Role: lead
Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation
Role: lead
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
Role: lead
Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation
Role: collaborator
A Study to Evaluate the Ocular Blood Flow Effects of Unoprostone Isopropyl in Adults With Dry Age-related Macular Degeneration
Role: lead
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
Role: lead
Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and Chemotherapy
Role: lead
Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension
Role: lead
Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation
Role: lead
All 18 trials loaded